Second Sight Medical Products Inc
EYESW · NASDAQ
12/31/2024 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $3 |
| % Growth | -100% | -74% | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $2 |
| Gross Profit | $0 | $0 | $0 | $1 |
| % Margin | – | 50% | 50% | 36.3% |
| R&D Expenses | $16 | $0 | $0 | $13 |
| G&A Expenses | $9 | $0 | $0 | $9 |
| SG&A Expenses | $9 | $0 | $0 | $15 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $6 |
| Other Operating Expenses | $0 | $0 | $0 | $3 |
| Operating Expenses | $25 | $0 | $0 | $32 |
| Operating Income | -$25 | -$0 | -$15 | -$34 |
| % Margin | – | -3,431.2% | -1,489,600% | -1,004.9% |
| Other Income/Exp. Net | $1 | $9 | $15 | $0 |
| Pre-Tax Income | -$23 | -$0 | -$0 | -$34 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$23 | -$0 | -$0 | -$34 |
| % Margin | – | -3,431.2% | -1,488% | -994.1% |
| EPS | -0.43 | -0 | -0.001 | -1.02 |
| % Growth | -143,233.3% | 40% | 100% | – |
| EPS Diluted | -0.43 | -0 | -0.001 | -1.02 |
| Weighted Avg Shares Out | 55 | 33 | 33 | 33 |
| Weighted Avg Shares Out Dil | 55 | 33 | 33 | 33 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$25 | -$9 | -$15 | -$34 |
| % Margin | – | -3,435,769.2% | -1,489,600% | -1,004.9% |